Previous close | 103.44 |
Open | 105.30 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 105.20 - 106.79 |
52-week range | 95.73 - 125.00 |
Volume | |
Avg. volume | 30,103 |
Market cap | 278.202B |
Beta (5Y monthly) | 0.29 |
PE ratio (TTM) | 22.93 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.29 (3.18%) |
Ex-dividend date | 22 Apr 2024 |
1y target est | N/A |
KRYAY vs. NSRGY: Which Stock Is the Better Value Option?
JPMorgan has turned positive on Unilever (LON:ULVR), after several years of caution, but has taken a more cautious view on Nestle (SIX:NESN) as its earnings growth moderates. Unilever has instituted several changes over the past 12 months, analysts at JPMorgan said in a note dated May 23, which have soothed the bank’s concerns, including cultural change and corporate governance; market share underperformance through increased investments and execution focus; and portfolio transformation with disposals. This feeds a stronger FY24, and should give credence to Unilever is on the path to turnaround and contribute to the stock re-rating along with positive earnings revision.
Weight loss drugs are rising in popularity, and food companies are cooking up new ways to win over those consumers.